PARIS (Reuters) -Danone on Tuesday reported third-quarter sales that beat expectations, boosted by strong demand in China for infant milk formula and medical nutrition products, largely offsetting weakness in coffee creamers amid a competitive U.S. market.
The French consumer goods group, whose brands include Evian and Badoit water and Activia yoghurt, said third-quarter sales reached 6.876 billion euros ($8.02 billion), marking growth of 4.8% on a like-for-like basis, compared with expectations of 4.3% growth in a company-provided analysts' consensus.
Danone reiterated its full-year 2025 forecast was in line with its mid-term ambition of like-for-like sales growth of between 3% and 5%, with recurring operating income growing faster than sales.
($1 = 0.8575 euros)
(Reporting by Dominique Vidalon;Editing by Sudip Kar-Gupta)
